Extensions

Analysis of US Patent 10,792,416

Date of Analysis: May 13, 2026

This analysis details the patent term, application history, and family members related to US Patent 10,792,416.

Patent Term and Expiration

• Patent Term Adjustment (PTA): This patent includes a significant Patent Term Adjustment, which extends its life beyond the standard 20-year term to compensate for administrative delays by the USPTO during prosecution. Based on the provided data, a PTA of 526 days has been granted.
• Patent Term Extension (PTE): There is no evidence of a Patent Term Extension (PTE) under 35 U.S.C. § 156. PTE is typically granted for delays caused by regulatory review (e.g., FDA approval) and is not indicated for this patent.
• Projected Expiration Date: The application for this patent family claims priority from the filing date of a parent application, May 30, 2017. The standard 20-year term would therefore expire on May 30, 2037. With the addition of the 526-day PTA, the adjusted expiration date for US Patent 10,792,416 is November 7, 2038. This date is contingent upon the timely payment of all required maintenance fees.

Continuity and Application History

US Patent 10,792,416, which issued from application 15/793,339, is part of a large and ongoing family of related patent applications.

• Parent Application: This patent is a continuation-in-part of U.S. application 15/608,183 (filed May 30, 2017), which issued as US Patent 10,758,652. This relationship is explicitly stated in the patent's description.
• Continuation Applications (Children): This patent serves as the parent for a series of subsequent continuation applications, indicating a strategy by the assignee, Haemonetics Corp, to protect ongoing innovation in this area. Known continuation applications include:
  • 16/931,333 (filed Jul. 16, 2020), now US Patent 10,980,934.
  • 17/205,400 (filed Mar. 18, 2021), now US Patent 12,186,474.
  • 18/606,761 (filed Mar. 15, 2024), now pending.
  • 19/077,384 (filed Mar. 12, 2025), now active.
  • 19/275,431 (filed Jul. 21, 2025), now pending.
• Divisional Applications: The provided records do not indicate any divisional applications stemming from application 15/793,339. The subsequent filings are identified as continuations.

International Patent Family

The U.S. patent family is related to an international PCT application, PCT/US2018/057528, which has led to the filing of corresponding patents in numerous jurisdictions worldwide. This demonstrates a broad international filing strategy. According to the provided patent data, related family members have been published in:

• Australia (AU)
• Canada (CA)
• China (CN)
• Europe (EP)
• Japan (JP)
• South Korea (KR)
• Russia (RU)
• Saudi Arabia (SA)